AzTrials
AzTrials

Hospital Acquired ConditionMEP-VRNCT06469554

Effect of a Multicomponent Exercise Program With Virtual Reality (MEP-VR) vs Standard Approaches on Functional and Cognitive Domains in Hospitalized Geriatric Patients: Study Protocol for a Randomized Controlled Trial.

A study testing MEP-only group and MEP-VR group in people with Hospital Acquired Condition and Frailty, run by Fundacion Miguel Servet at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to test the effectiveness of a Multicomponent Exercise Program with Virtual Reality (MEP-VR) compared to a Multicomponent Exercise Program (MEP-only) or usual care, in terms of functional and cognitive outcomes in hospitalized older adults. Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
Hospital Acquired Condition, Frailty
What is being tested?
MEP-only group and MEP-VR group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
156 participants
Where
1 siteSpain
Study dates
1 Jan 2024to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Age 75 years or older
  • Barthel Index score of at least 60 points
  • Able to walk and cooperate
  • Estimated hospital stay of at least 4 days
  • Able to provide informed consent

Who cannot join

  • Severe dementia
  • Terminal illness
  • Clinical instability

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Universitario de Navarra

    Pamplona, Navarre, 31008

Other trials in Spain

About this study

Official title: Effect of a Multicomponent Exercise Program With Virtual Reality (MEP-VR) Versus Standard Approaches on Functional and Cognitive Domains in Hospitalised Geriatric Patients: Study Protocol for a Randomized Controlled Trial

The goal of this clinical trial is to test the effectiveness of a Multicomponent Exercise Program with Virtual Reality (MEP-VR) compared to a Multicomponent Exercise Program (MEP-only) or usual care, in terms of functional and cognitive outcomes in hospitalized older adults.

The main questions it aims to answer are:

Read more
  • Does the MEP-VR program improve the functionality of hospitalized older adults compared to the other groups?
  • Does the MEP-VR program improve the cognitive, mood, and quality of life outcomes of hospitalized older adults compared to the other groups?

Participants will be randomly assigned to one of three groups: a control group or one of the two intervention groups. The intervention groups will receive either the MEP-VR or MEP-only program, which consists of supervised aerobic exercise, resistance training, and balance training, with or without a virtual reality component designed specifically for this study. The intervention will take place over four consecutive days, with each session lasting 30-40 minutes.

The primary outcome will be the functional changes at the time of discharge. Cognition, mood, quality of life, and VR usability will also be assessed.

Technological advances are rapidly increasing with population aging, creating potential benefits for integrating technology into the care of older adults. This study comprehensively evaluates the implementation of VR combined with the multicomponent exercise program. If the hypothesis is confirmed, it would pave the way for modifying the hospitalization system and reducing the critical healthcare burden resulting from the commonly acquired disability in the older population.

Read the detailed description

Acute hospitalization often leads to functional impairment and disability in older adults as a side effect. Reduced physiological resources increase the risk of negative consequences like functional and cognitive decline, longer hospital stays, and higher mortality and institutionalization rates. Approximately 30-50% of hospitalized older adults experience functional decline, which increases their risk of worsening function or death in the year after discharge.

Conventional care models tend to overlook the negative effects of hospitalization and fail to leverage the potential benefits of technology. Recent studies have found that physical exercise and early rehabilitation programs can prevent functional and cognitive decline during hospitalization and reduce hospital stay and mortality. While Multicomponent Exercise Programs (MEP) that focus on promoting mobility have shown benefits, adding virtual reality (VR) to MEP (MEP-VR) may provide additional physical and cognitive performance improvements in hospitalized patients.

VR is an emerging tool that can engage older adults in physical and cognitive activities. Immersive VR (IVR) systems like head-mounted displays can transport users into virtual environments to execute activities and stimulate cognitive skills. VR is considered an affordable, novel, and safe tool, but further research is needed on its benefits and limitations for older adults.

The main aim of this study is to investigate the effects of MEP-VR on functional and cognitive outcomes in hospitalized older adults compared to standard care. It will also assess the effects on mood, safety, and usability.

Methods

This will be a three-arm randomized clinical trial with two experimental intervention groups (MEP-only, MEP-VR) and a control group (usual care). It will be conducted in the Acute Geriatric Unit (AGU) at a hospital in Spain.

Eligible patients aged 75+ with a Barthel Index score of at least 60, who can walk and cooperate, have an estimated hospital stay of at least 4 days, and provide informed consent, will be randomly assigned to one of the three groups. Those with severe dementia, terminal illness, or clinical instability will be excluded.

The MEP-only group will receive supervised aerobic, resistance, and balance training over 4 consecutive days. The MEP-VR group will receive the same MEP with the addition of IVR components, including using VR during the bike warm-up and while doing resistance exercises. The control group will receive usual care.

Outcomes will be assessed at baseline, end of intervention, and 3 months post-discharge. The primary outcome is functional changes at discharge, measured by the Short Physical Performance Battery, Timed Up and Go, Barthel Index, handgrip strength, and 1-repetition maximum strength tests. Secondary outcomes include cognition, mood, quality of life, and VR-related measures like usability and cybersickness.

The study will be conducted according to randomization and blinding principles. The researcher assigning groups will be different from the attending geriatrician. Patients/caregivers will be blinded to group allocation. Assessors will be blinded but intervention staff will not. Adverse events and dropouts will be recorded.

The study was approved by the ethics committee and registered at ClinicalTrials.gov.

Intervention Details

The MEP-only intervention will consist of:

7-10 min warm-up on a stationary bike 15-20 min resistance training using weight machines 10 min balance training using light-based exercises

The MEP-VR intervention will include the same MEP components plus:

VR during the bike warm-up, allowing patients to virtually tour different locations VR during resistance exercises, with a virtual rural environment displayed The VR system was developed using Unity, C++, OpenXR, and Low Poly graphics for optimal performance and visual comfort The usual care control group will receive standard hospital care, including physical rehabilitation if needed.

Outcomes

Primary outcome: Changes in functional capabilities during the study period, assessed through:

Short Physical Performance Battery Timed Up and Go test Barthel Index Handgrip strength

1-repetition maximum strength tests

Secondary outcomes:

Changes in cognitive function (Mini-Mental State Exam) Changes in mood (Geriatric Depression Scale, Anxiety Inventory) Quality of life (EuroQol-5D-5L) VR-related outcomes (usability, cybersickness, satisfaction) Adverse events, adherence, and perceived exertion Discussion

This study focuses on developing individualized, multicomponent programs to address and prevent functional decline in hospitalized older adults by incorporating innovative technologies like VR. Advances in technology are increasing concurrently with population aging, presenting opportunities to integrate technology into elder care. However, older adults are often excluded from research, leading to limited knowledge on the potential benefits of these technologies.

This randomized trial comprehensively evaluates the implementation of IVR combined with a multicomponent exercise program. It assesses whether IVR can provide greater motivation and willingness to exercise, leading to greater functional and cognitive improvements, as well as impacts on mood, quality of life, and feasibility.

If the hypothesis is confirmed, this project could pave the way for modifying the hospitalization system to leverage technology and help reduce the critical healthcare burden resulting from hospital-acquired disability in older adults

Being tested
MEP-only group, MEP-VR group
Keywords
Hospital-associated functional decline, Cognitive stimulation, Physical exercise, Virtual Reality, Multicomponent exercise program
Medical subject headings
Iatrogenic Disease, Frailty, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MEP-only groupBehavioural

    Participants in this group will receive a Multicomponent Exercise Program (MEP) consisting of: Supervised aerobic training on a stationary bike Progressive resistance/strength training using weight machines Balance training exercises The MEP sessions will be 30-40 minutes long and conducted over 4 consecutive days.

  • MEP-VR groupBehavioural

    Participants in this group will receive the same MEP intervention as the MEP-only group.

    Additionally, they will use an immersive virtual reality (IVR) system during the exercise program

Study groups in NCT06469554
Study groupRoleWhat they receive
Usual Care GroupNo interventionParticipants randomly assigned to this group will receive standard hospital care, which may include physical rehabilitation if deemed necessary by the clinical staff.
Intervention groupExperimentalParticipants in this group will receive a Multicomponent Exercise Program (MEP) or with virtual reality added
Receives: Behavioral: MEP-only group; Behavioral: MEP-VR group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Short Physical Performance Battery (SPPB)

    The Short Physical Performance Battery (SPPB) is a validated instrument used for detecting frailty and predicting disability, institutionalization, and mortality in older adults. It includes the following three tests: Balance tests: Side-by-side stand Semi-tandem stand Tandem stand Gait speed test: Participants are timed walking 4 meters at their usual pace. Chair stand test: Participants are timed as they rise from a chair and return to a seated position five times without using their arms. The SPPB provides a total score ranging from 0 (worst performance) to 12 (best performance) points by summing the scores from each of the three components. Lower SPPB scores indicate poorer physical function and higher risk of adverse health outcomes. The SPPB is a widely used and reliable measure of physical performance in older adults, making it a suitable primary outcome for assessing the functional changes in this study population of hospitalized older individuals

    Measured: Measured at baseline, end of 4-day intervention, and 3 months post-discharge.

  2. Timed Up and Go (TUG)

    The Timed Up and Go (TUG) test is used to assess dynamic balance and risk of falling in older adults. It measures the time in seconds it takes for an individual to get up from a chair, walk 3 meters, and return to the chair

    Measured: The TUG will be administered at the same three time points as the other primary outcome measures: At the start of the 4-day intervention during acute hospitalization At the end of the 4-day intervention 3 months after hospital discharge during the outpa

Secondary outcomes (5)
  1. Mini-Mental State Examination (MMSE)

    Cognitive evaluation

    Measured: through study completion, an average of 1 year

  2. Geriatric Depression Scale (GDS):

    Specifically designed to assess depression in older adults 15-item questionnaire with a scale ranging from 0 (best) to 15 (worst)

    Measured: through study completion, an average of 1 year

  3. State-Trait Anxiety Inventory (STAI)

    Assesses both state anxiety (current, transient feelings) and trait anxiety (general, long-term tendency) Contains separate scales for state anxiety and trait anxiety Measures overall anxiety levels, not specifically depression

    Measured: through study completion, an average of 1 year

  4. Self-perceived acceptance, usability, and satisfaction using the System Usability Scale

    The SUS is a 10-question survey that measures a user's subjective assessment of a system's usability on a scale from 1 (lower) to 5 (higher). This validated scale will be used to assess the participants' perceptions of the acceptability, usability, and satisfaction with the VR components integrated into the MEP-VR intervention.

    Measured: The SUS will be administered during the 4-day intervention period, while the participants are actively using the VR system as part of the MEP-VR program

  5. EuroQol-5D-5L questionnaire

    It consists of two main components: Descriptive system: Assesses five dimensions of health status: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is scored on a 5-point scale from 1 (no problems) to 5 (extreme problems). Visual Analogue Scale (VAS): Allows the participant to rate their overall health on a vertical scale from 0 (worst health state imaginable) to 100 (best health state imaginable). The EQ-5D-5L provides a profile of the respondent's health status across the five dimensions, as well as a single index value for their overall health-related quality of life. Timing: In this study, the EQ-5D-5L will be administered at three time points: At the start of the 4-day intervention during acute hospitalization At the end of the 4-day intervention 3 months after hospital discharge during the outpatient follow-up visit

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2024
  2. Study start1 Jan 2024
  3. Primary completion31 Dec 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
156 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06469554
Sponsor's protocol ID
MEP-VR
Acronym
MEP-VR
Status last verified
Jun 2025
First submitted
12 Jun 2024
Last updated
10 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Sharing study data upon reasonable request Individual participant data (IPD) collected in this randomized controlled trial will be available for sharing upon reasonable request. This includes basic demographic data as well as results from assessments of functionality, cognition, mood, quality of life, and virtual reality experience. Researchers interested in accessing these IPD can contact the research team. Requests will be evaluated, and if approved, data will be shared in a timely manner while maintaining participant confidentiality and privacy. This data sharing aims to foster scientific collaboration, enable secondary analyses, and replicate the findings, contributing to the advancement of knowledge in geriatric rehabilitation and emerging technologies. Instructions for requesting IPD access will be available at \[website/research team contact\]. All requests will be fairly and transparently reviewed to ensure compliance with ethical and data protection standards.

Publications

  • Ferrara MC, Zambom-Ferraresi F, Galbete A, Fernandez-Gonzalez de la Riva M, Izco-Cubero M, Garcia-Baztan A, Capon-Saez A, Dominguez-Mendoza S, Marin-Epelde I, Zambom-Ferraresi F, Martinez-Velilla N. Effect of a Multicomponent Exercise Program with Virtual Reality (MEP-VR) versus standard approaches on functional and cognitive domains in hospitalised geriatric patients: Study protocol for a randomized controlled trial. Rev Esp Geriatr Gerontol. 2025 Jul-Aug;60(4):101646. doi: 10.1016/j.regg.2025.101646. Epub 2025 Mar 13.

    PubMed 40086340

Questions about this trial

What is this clinical trial studying?

A study testing MEP-only group and MEP-VR group in people with Hospital Acquired Condition and Frailty, run by Fundacion Miguel Servet at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Short Physical Performance Battery (SPPB) (time frame: Measured at baseline, end of 4-day intervention, and 3 months post-discharge.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06469554, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in